FTC sues major pharmacy profit managers above insulin rates The agency brought motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the checklist price of lifestyle-conserving insulin medications. Before this summer time, the agency held prolonged negotiations with Steward over https://edgarlcukz.bloggin-ads.com/54021125/considerations-to-know-about-healthcare-news